Zivo Bioscience Reports on Shareholder Vote Matters
Ticker: ZIVOW · Form: 8-K · Filed: Jun 13, 2024 · CIK: 1101026
| Field | Detail |
|---|---|
| Company | Zivo Bioscience, Inc. (ZIVOW) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
ZIVO shareholders voted on something important June 11th. Details to follow.
AI Summary
Zivo Bioscience, Inc. filed an 8-K on June 13, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 11, 2024. The company, incorporated in Nevada, is in the biological products sector and is headquartered in Bloomfield Hills, Michigan.
Why It Matters
This filing indicates that Zivo Bioscience held a shareholder vote, which is a key event for corporate governance and potential strategic decisions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain immediate financial or operational risks.
Key Players & Entities
- Zivo Bioscience, Inc. (company) — Registrant
- June 11, 2024 (date) — Date of earliest event reported
- June 13, 2024 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- 21 East Long Lake Road, Suite 100, Bloomfield Hills, MI 48304 (address) — Business and mail address
FAQ
What specific matters were submitted for a vote of Zivo Bioscience's security holders on June 11, 2024?
The filing states that matters were submitted to a vote of security holders on June 11, 2024, but does not specify the exact nature of these matters within the provided text.
When was the Form 8-K filed with the SEC?
The Form 8-K was filed on June 13, 2024.
What is Zivo Bioscience, Inc.'s Standard Industrial Classification (SIC) code?
Zivo Bioscience, Inc.'s SIC code is 2836, for Biological Products (No Diagnostic Substances).
In which state is Zivo Bioscience, Inc. incorporated?
Zivo Bioscience, Inc. is incorporated in Nevada.
What is the business address of Zivo Bioscience, Inc.?
The business address is 21 East Long Lake Road, Suite 100, Bloomfield Hills, MI 48304.
Filing Stats: 604 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-06-13 16:47:53
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ZIVO OTCQB Warrants to p
Filing Documents
- zivo_8k.htm (8-K) — 37KB
- 0001654954-24-007730.txt ( ) — 170KB
- zivo-20240611.xsd (EX-101.SCH) — 6KB
- zivo-20240611_lab.xml (EX-101.LAB) — 15KB
- zivo-20240611_cal.xml (EX-101.CAL) — 1KB
- zivo-20240611_pre.xml (EX-101.PRE) — 11KB
- zivo-20240611_def.xml (EX-101.DEF) — 4KB
- zivo_8k_htm.xml (XML) — 5KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. At the annual meeting of shareholders (the "Annual Meeting") of Zivo Bioscience, Inc. (the "Company") held on June 11, 2024, shareholders (i) elected one Class II director to the Company's Board of Directors to serve a three-year term until the 2027 annual meeting of shareholders, (ii) ratified the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, and (iii) approved (on an advisory basis) the compensation of the Company's named executive officers. These proposals are described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 26, 2024. A total of 1,862,320 shares of the Company's common stock were present at the meeting in person or by proxy, which represents approximately 66.4% of the shares of common stock outstanding as of the record date for the Annual Meeting. According to the final vote, the Company's stockholders approved all three proposals. The final results of the voting are shown below: Proposal 1—Election of One Class II Director Nominee Votes For Votes Withheld Broker Non-Votes Nola E. Masterson 1,155,796 80,935 625,589 Proposal 2—Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 1,767,252 94,680 388 Proposal 3 — Approval (on an Advisory Basis) of the Compensation of the Company's Named Executive Officers Votes For Votes Against Votes Abstain Broker Non-Votes 1,191,591 44,773 367 625,589 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZIVO BIOSCIENCE, INC. By: /s/ Keith Marchiando Keith Marchiando Chief Financial Officer Date: June 13, 2024 3